A study has identified four distinct clusters of symptoms, including psychiatric and cardiovascular, that can progressively lead to Alzheimer's disease -- an ageing-related condition in which memory ...

Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.